Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Xencor on the deal.Xencor, a clinical-stage biopharmaceutical company, announced its $100 million collaboration agreement with Johnson & Johnson…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
